UNSPSC 51112609: Neptamustine or pentamustine

This classification denotes a nitrosourea compound, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VB67O9FBGM. European Medicines Agency schedules Neptamustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09201MIG. Neptamustine generally arises in the molecular formula C8H16CLN3O2.

The term NEPTAMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) NEPTAMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Neptamustine or pentamustine bears US NLM identifiers UMLS ID C1882315 and NCI Concept Code C66341. SMILES: CLCCN(N=O)C(=O)NCC(C)(C)C.

UNSPSC 51112609 Neptamustine or pentamustine is a Commodity code covering the procurement of these specific chemotherapy agents by state and local health systems. State and local governments purchase these mustard-derivative drugs for oncology treatment programs, typically through health departments, public hospital systems, and correctional-health procurement units. The code represents a narrow pharmaceutical segment distinct from broader chemotherapy or cancer-treatment procurement — it tags only these two agents by chemical name rather than therapeutic class.

The source provided contains no recent state or local contract opportunities posted under this code.